Page last updated: 2024-11-05

n-phenylethanolamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID31235
CHEMBL ID1908069
CHEBI ID194595
SCHEMBL ID8115
MeSH IDM0046819

Synonyms (68)

Synonym
BIDD:GT0313
nsc-8393
n-phenylethanolamine
wln: q2mr
2-(phenylamino)ethanol
n-(.beta.-hydroxyethyl)aniline
benzenamine, n-(2-hydroxyethyl)-
ethanol, 2-(phenylamino)-
(.beta.-hydroxyethyl)aniline
122-98-5
nsc8393
ethanol, 2-anilino-
aniline, n-(.beta.-hydroxyethyl)-
n-(2-hydroxyethyl)aniline
aniline, n-(2-hydroxyethyl)-
2-anilinoethanol ,
n-(2-hydroxyethyl)phenylamine
.beta.-anilinoethanol
einecs 204-588-1
ai3-02009
aniline, n-(beta-hydroxyethyl)-
(beta-hydroxyethyl)aniline
n-(beta-hydroxyethyl)aniline
phenyl ethanolamine
beta-anilinoethanol
brn 0774672
emery 5700
nsc 8393
OPREA1_280517
inchi=1/c8h11no/c10-7-6-9-8-4-2-1-3-5-8/h1-5,9-10h,6-7h
n-(2-hydroxyethyl)aniline, 98%
A0466
n-hydroxyethyl aniline
CHEBI:194595
AKOS000120292
n-hydroxyethylaniline
2-anilino-ethanol
unii-630dl2n96b
630dl2n96b ,
4-12-00-00277 (beilstein handbook reference)
ec 204-588-1
BBL011612
STK943765
2-(phenylamino)ethan-1-ol
n-phenyl-2-aminoethanol
CHEMBL1908069
n-(2-hydroxyethyl)-aniline
n-(2 hydroxy ethyl) aniline
n-(2 hydroxy ethyl)aniline
n-beta-hydroxyethylaniline
2-(phenylamino) ethanol
phenylglycinol
2-phenylaminoethanol
npea
2-anilino ethanol
SCHEMBL8115
DTXSID8059550
STR06691
W-108418
F2190-0412
mfcd00002832
n-(2-hydroxyethyl)aniline, technical, >=98.0% (t)
FT-0743890
CS-W016519
Q15632814
EN300-20660
D70504
phenyl glycinol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aralkylamineAn alkylamine in which the alkyl group is substituted by an aromatic group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID624614Specific activity of expressed human recombinant UGT2A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (25.00)18.7374
1990's1 (1.92)18.2507
2000's19 (36.54)29.6817
2010's19 (36.54)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.25 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]